Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (24)

2024

  1. Cost–Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study

    Diseases, Vol. 12, Núm. 10

  2. Incidence and causes of hospitalization in patients with transthyretin (ATTR-CA) and light chain (AL-CA) cardiac amyloidosis

    Medicina Clinica, Vol. 162, Núm. 7, pp. e1-e7

  3. Prognostic value of the tricuspid annular plane systolic excursion/systolic pulmonary artery pressure ratio in cardiac amyloidosis

    Revista Espanola de Cardiologia, Vol. 77, Núm. 8, pp. 634-644

  4. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

  2. Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881

  3. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204

2022

  1. Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy

    Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273

  2. Cardiac amyloidosis: Description of a series of 143 cases

    Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213

  3. Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes

    Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428

  4. Telemedicine consultation and evolutionary model in outpatient care of cardiovascular processes

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 97-106

2020

  1. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  2. Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 643-651

2016

  1. Acute Arterial Hypertension in Acute Pulmonary Edema: Mostly a Trigger or an Associated Phenomenon?

    Canadian Journal of Cardiology, Vol. 32, Núm. 10, pp. 1214-1220

  2. Hospital and 4-year mortality predictors in patients with acute pulmonary edema with and without coronary artery disease

    Journal of the American Heart Association, Vol. 5, Núm. 2

  3. Unruptured sinus of Valsalva aneurysm presenting as NSTEMI

    Archivos de Cardiologia de Mexico, Vol. 86, Núm. 4, pp. 376-377

2015

  1. Clinical Practice Guideline (CPG). Recommendations on strategy for reducing risk of heart failure patients requiring noncardiac surgery: Reducing risk of heart failure patients in noncardiac surgery

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 62, Núm. 7, pp. 359-419

  2. Post-introduction observation of transcatheter aortic valve implantation in Galicia (Spain)

    Journal of Evaluation in Clinical Practice, Vol. 21, Núm. 1, pp. 34-42

2014

  1. Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction

    Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 716-726

2011

  1. Modelo de intervención coronaria percutánea primaria en la Comunidad de Galicia

    Revista Espanola de Cardiologia Suplementos, Vol. 11, Núm. SUPPL. 3, pp. 44-50